CY1114137T1 - PHARMACEUTICAL COMPOSITION CONTAINING AN ANDROGEN - Google Patents

PHARMACEUTICAL COMPOSITION CONTAINING AN ANDROGEN

Info

Publication number
CY1114137T1
CY1114137T1 CY20131100110T CY131100110T CY1114137T1 CY 1114137 T1 CY1114137 T1 CY 1114137T1 CY 20131100110 T CY20131100110 T CY 20131100110T CY 131100110 T CY131100110 T CY 131100110T CY 1114137 T1 CY1114137 T1 CY 1114137T1
Authority
CY
Cyprus
Prior art keywords
composition
androgen
pharmaceutical composition
composition containing
patient
Prior art date
Application number
CY20131100110T
Other languages
Greek (el)
Inventor
Robert Gyurik
Original Assignee
Fcb I Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from EP06018822A external-priority patent/EP1741433B1/en
Application filed by Fcb I Llc filed Critical Fcb I Llc
Publication of CY1114137T1 publication Critical patent/CY1114137T1/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Μια φαρμακευτική σύνθεση η οποία περιλαμβάνει: (Α) ένα ανδρογόνο· (Β) έναν κυκλικό ενισχυτή του τύπου που χρησιμοποιείται στις συνθέσεις και μεθόδους που αξιώνονται από το Δίπλωμα Ευρεσιτεχνίας των ΗΠΑ No. 5,023,252 του Hsieh· και (C) έναν παράγοντα αύξησης του ιξώδους· περιλαμβάνοντας, για παράδειγμα, μια σύνθεση στην οποία ο κυκλικός ενισχυτής είναι ένας μακροκυκλικός εστέρας ή μια μακροκυκλική κετόνη· τη χρήση της σύνθεσης για την αντιμετώπιση μιας κατάστασης, για παράδειγμα, ανδρικού υπογοναδισμού, σε έναν ασθενή μέσω εφαρμογής της σύνθεσης στη μεμβράνη του ασθενούς· και μια μέθοδο παρασκευής της σύνθεσης.A pharmaceutical composition comprising: (A) an androgen; (B) a cyclic enhancer of the type used in the compositions and methods claimed by U.S. Pat. And (C) a viscosity enhancing agent; including, for example, a composition in which the cyclic enhancer is a macrocyclic ester or a macrocyclic ketone; the use of the composition to treat a condition, for example, of male hypogonadism , to a patient by applying the composition to the patient's membrane; and a method of preparing the composition.

CY20131100110T 2002-04-19 2013-02-06 PHARMACEUTICAL COMPOSITION CONTAINING AN ANDROGEN CY1114137T1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US37410302A 2002-04-19 2002-04-19
EP06018822A EP1741433B1 (en) 2002-04-19 2003-04-21 Pharmaceutical composition comprising an androgen

Publications (1)

Publication Number Publication Date
CY1114137T1 true CY1114137T1 (en) 2016-07-27

Family

ID=58449045

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20131100110T CY1114137T1 (en) 2002-04-19 2013-02-06 PHARMACEUTICAL COMPOSITION CONTAINING AN ANDROGEN

Country Status (1)

Country Link
CY (1) CY1114137T1 (en)

Similar Documents

Publication Publication Date Title
CY1109005T1 (en) PHARMACEUTICAL COMPOSITION CONTAINING AN ANDROGEN
EA200501562A1 (en) MEDICAL IMPLANTS CONTAINING BIOS COMPATIBLE COATINGS
CY1106468T1 (en) SUBSTITUTED CYCLOHEXANE-1,4-DIAMINE DERIVATIVES
RS49756B (en) Use of xenon for preparing a pharmaceutical preparation for treating neurointoxications
CY1113039T1 (en) ELECTRIC AND MALONIC TRANS-4- (1R, 3S) -6-CHLORO-3-FINYLINDAN-1-Yl) -1,2,2-TRIMETHYLPIPERAZINE AND USE FOR MEDICINE
CY1115117T1 (en) Derivatives of Substituted Oxazolidinones and Their Use as Suspending Agents
CY1107294T1 (en) LOCAL COMPOSITION CONTAINING A VITAMIN D OR A VERSION OF VITAMIN D AND A VULNERABLE CYTICOSTEROID
CL2003002767A1 (en) ORAL COMPOSITION THAT INCLUDES A FILM CONTAINING A FUNCTIONAL MATERIAL, IN A VEHICLE, USEFUL FOR ORAL CARE.
SV2004001556A (en) ACID PREPARATIONS OF INSULIN WITH IMPROVED STABILITY
CO5700698A2 (en) COMPOSITIONS AND METHODS FOR ORAL AND PERSONAL CARE
BRPI0413728B8 (en) human tear lipocalin mutein, methods for generating and producing mutein, pharmaceutical composition and use of mutein
CY1106682T1 (en) LAKTAMIS ASSOCIATION
CY1108797T1 (en) A-CRYSTAL FORM OF RANELIC STRONTIUM, METHOD OF PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING IT
DK1313462T3 (en) Use of Asian acid or asiaticoside for the treatment of cancer
DE60133817D1 (en) PROCESS FOR PREPARING APLIDINE AND NEW ANTITUMOROUS DERIVATIVES, PROCESS FOR THEIR PRODUCTION AND THEIR USE
CY1107231T1 (en) Substituted 4-Aminocyclohexanol derivatives
ATE252365T1 (en) COMPOSITIONS CONTAINING ORGANOSILOXANE RESINS FOR THE RELEASE OF ORAL CARE INGREDIENTS
BRPI0401182A (en) Make-up, process for coloring human keratically fibers, process for coloring dark skin, multi-compartment device and use of a make-up
ATE464878T1 (en) PHARMACEUTICAL COMPOSITION FOR NASAL USE OF FENTANYL
HUP0200055A2 (en) 16-hydroxyestrienes and pharmaceutical compositions containing the same
ATE527377T1 (en) CREATION OF GENE EXPRESSION PROFILES FROM FFPE SAMPLES
TW200509863A (en) Irradiation device for medical use
CY1114137T1 (en) PHARMACEUTICAL COMPOSITION CONTAINING AN ANDROGEN
HUP0102226A2 (en) Hyperforin derivatives, the use thereof and formulations containing them
DE60335892D1 (en) PHARMACEUTICAL COMPOSITION RELATING TO THE PRODUCTION OF A MEDICAMENT FOR TREATMENT AND / OR PREVENTATION AND / OR OBSERVANCE OF FAT CONNECTION